对间歇性肺病病因发生的洞察 间歇性肺病病因的洞察
Eirini Vasarmidi1,2, Julie C Worrell3,2, Irma Mahmutovic Persson4,5,2
1Department of Respiratory Medicine, Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece.
Breathe (Sheffield, England)
|May 14, 2025
概括
间歇性肺部疾病 (ILD) 涉及遗传和环境因素,纤维细胞和巨细胞驱动纤维化. 个性化管理和了解免疫反应是ILD治疗新疗法选择的关键.
科学领域:
- 翻译科学是翻译的科学.
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
背景情况:
- 间歇性肺部疾病 (ILD) 是复杂的,受遗传和环境因素的影响.
- 纤维细胞和特定的巨细胞亚型 (M2) 是ILD病原体的核心,驱动纤维化.
- 慢性2型免疫在与ILD相关的纤维化中起作用.
研究的目的:
- 从翻译科学的角度回顾ILDs的关键特征.
- 探索ILDs的潜在治疗目标和策略.
- 突出个人化管理在ILDs的重要性.
主要方法:
- 文献综述侧重于ILDs的翻译方面.
- 分析纤维细胞,巨细胞和免疫反应在ILD中的作用.
- 评估目前和潜在的生物标志物和动物模型用于ILD研究.
主要成果:
- 遗传和环境因素显著影响ILD的发病,进展和治疗反应.
- 纤维细胞和M2巨细胞是纤维化症的关键驱动因素,代表治疗点.
- 血清生物标志物 (KL-6,SFTP-D,MMP-7,CCL-18) 显示出诊断和预后价值,需要进一步的临床验证.
- 动物模型提供了洞察力,但需要仔细选择和验证以获得翻译相关性.
结论:
- 个性化管理策略对于ILDs至关重要.
- 向纤维细胞,巨细胞和免疫反应提供了有希望的治疗途径.
- 需要进一步的研究来将临床前发现和生物标志物转化为ILDs的有效临床应用.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
357
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.0K
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pneumonia II: Pathophysiology
191
The pathophysiology of pneumonia involves the following steps:
191
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
